Natco Pharma Ltd. - Research Center
524816 NATCOPHARM Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 1,978.80 | 1,156.80 | 1,043.60 | 724.20 | 1,011.10 |
| Operating profit | 946.00 | 449.50 | 50.00 | 163.00 | 263.00 |
| Interest | 6.20 | 4.40 | 8.30 | 5.00 | 6.00 |
| Gross profit | 979.10 | 494.50 | 83.70 | 210.60 | 304.10 |
| EPS (Rs) | 42.77 | 18.94 | 0.56 | 7.06 | 10.86 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 39.30 | 49.40 | 42.00 | 52.60 | 47.10 |
| Stock adjustment | 39.50 | - | 62.80 | -68.30 | 9.70 |
| Raw material | 302.70 | 196.20 | 293.70 | 225.50 | 208.00 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 226.00 | 236.50 | 210.20 | 199.90 | 194.80 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 464.60 | 274.60 | 426.90 | 204.10 | 335.60 |
| Provisions made | - | - | - | - | - |
| Depreciation | 79.90 | 75.20 | 71.10 | 67.30 | 56.00 |
| Taxation | 133.70 | 73.60 | 2.30 | 14.50 | 50.50 |
| Net profit / loss | 765.50 | 345.70 | 10.30 | 128.80 | 197.60 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 35.80 | 36.50 | 36.50 | 36.50 | 36.40 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 47.81 | 38.86 | 4.79 | 22.51 | 26.01 |
| GPM (%) | 48.52 | 41.00 | 7.71 | 27.11 | 28.74 |
| NPM (%) | 37.93 | 28.66 | 0.95 | 16.58 | 18.67 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis